Summary.-We have studied the clonogenic capacity of tumour cells in agar from 38 malignant effusions from 31 patients with epithelial tumours. Colony formation of unfractionated cells varies considerably from patient to patient, and is positively correlated with the percentage of tumour cells in the sample. Clonogenicity was shown to be reduced in 8/9 cases by removal of plastic-adherent and iron-phagocytic cells. In the ninth case, increased clonogenicity occurred after this procedure. When the autologous adherent cells were removed from the effusion and used in reconstitution experiments as an underlayer in a two-layer agar system, they were able to reverse the effect of the initial fractionation in a dose-dependent fashion. This indicates cellular communication based on release of a diffusible product of plasticadherent cells. Morphological, phagocytic and prostaglandin-synthetic analysis of the fractions involved in the reconstitution experiments implicate the macrophage as the operative cell in this interaction. However, an accessory role for lymphoid cells or tumour cells themselves cannot be excluded.
HUMAN MALIGNANT EFFUSIONS contain a complicated mixture of cell types, including tumour cells, mesothelial cells, lymphocytes, macrophages and granulocytes (Light et al., 1973) . Such effusions have long provided biologists with convenient access to a cell suspension of human tumour tissue, and a number of epithelial tumour-cell lines have been derived from this source. The biological significance of the cell interactions occurring in malignant effusions are, however, relatively obscure. Tumour-lymphoreticular interaction has been studied extensively from the point of view of description and of specific cytotoxicity, both in animal and human tumours (Holden et al., 1976; Woodetal., 1975;  Underwood, 1974; Evans, 1976) . In addition, a number of reports have pointed to the fact that under certain circumstances there may be lymphoreticular stimulation of tumour growth (Norbury, 1977; Mantovani et al., 1979; Fidler et al., 1974) . Indeed, Prehn (1977) has proposed a "lymphodependent phase of tumor growth" and Salmon & Hamburger (1978) have hypothesized that tumour growth was macrophage-dependent, partly on the basis of studies of depletion of phagocytic cells from ovarian carcinoma effusions (Hamburger et al., 1978) . In the present study, we have examined the stoichiometry of the cellular interactions with the perspective that tumours are examples of cell-renewal systems in which the majority of the cell popuilation is maintained by the function of a few proliferative renewing cells (stem cells) (Steel, 1977) and may respond to growth stimulants or inhibitors from other cell populations. Tumour stem cells are considered to be critical in terms of Reprint requests to: Ronald N. Buick, Ph.D., Ontario Cancer Institute, 500 Sherbourne Street, Toronto, MI4X 1K9, Canadla. determination of response to treatment (Steel, 1977) and as such are the important cells to study from the point of view of putative host-cell-tumour interaction. One approach to assessment of tumour stem cells is the recent application of twolayer agar techniques to the assessment of clonogenic tumour cells (Hamburger et al., 1978; Hamburger & Salmon, 1977; Buick et al., 1979a) . This paper describes the application of fractionation and reconstitution experiments to the study of controlling influences on tumour clonogenicity from cells derived from malignant effusions, and provides evidence of major interaction between reactive host cells and the clonogenic human tumour cells.
METHODS
Patients.-Pleural or ascitic fluid (200-8000 ml) was obtained by paracentesis into heparinized (10 u/ml) vacuum bottles from 31 patients with histologically proven epithelial cancers (17 ovarian, 8 breast, 3 colon, 1 renal, 1 oat-cell, 1 thyroid). The presence of tumour cells in the fluid was checked by an independent pathologist (Dr J. Davis). None of the patients had been treated during the 4 weeks before the assay.
Cells. quently used for cell culture without removal of the adherent layer. In such experiments, adherent cell layers were prepared with serial increases in the number of cells permitted to adhere (104-107). As determined directly by microscopy, the number of cells adhering in any experiment was found to be a constant percentage of the number of cells plated from any one patient for the adherence procedure ( Fig. 1) (Jaffe & Behrman, 1974) .
Cell cultur-e.-A standard two-layer agar technique was used with the enrichments described by Hamburger & Salmon (1977 (Hamburger et al., 1978) immunofluorescence (Buick et al., 1979b) and by morphological criteria using a dried-agar-layer technique (Salmon & Buick, 1979) mnacrophages assessed by morphological analysis. Colony formation and cloning efficiency varied considerably, from 0 to 11,386 colonies/5 x 105 cells and from < 2 x 10-6, 3*2 x 10-2/tumour cell respectively. Separate analysis of ovarian (n = 20) or breast (n = 11) carcinoma samples showed that the two groups were not significantly different with respect to cellular differential, or to clonogenic efficiencies (Table Ib) . The higher mean clonogenic efficiency of ovarian effusions is due to the high clonogenicity of one sample (Pt 21b). The results of Spearman rank-correlation analysis of colony formation and cloning efficiency (CE) against each of the cell types of the effusion are shown in Table II Table IV . Prostaglandin synthetic capacity of fractions from 3 effusions are shown in Table V . The experiments described here analyse cell-cell interaction involved in the clonogenicity of tumour cells in malignant effusions of patients with epithelial cancer. In the total population studied, marked variation in clonogenicity and plating efficiency was seen when unfractionated cells from effusions were plated in a twolayer agar system. Correlation analysis (Table II) of this data with cellular differentials indicate that colony formation is positively correlated (r= 0-6179, P<0-01) with the percentage of tumour cells. There is no statistically significant correlation between cloning efficiency (colonies/tumour cell) and the percentages of either tumour cells, macrophages or lymphoid cells in the malignant effusion. Separate analysis of the 20 ovarian effusions demonstrated a similar correlation between colony formation and tumour-cell percentage, significant at the 1% level (r = 0.6225). The negative correlations between colony formation and lymphoid-cell percentage could be accounted for by the negative correlation between tumour cells and lymphoid cells (r= -0-8722, P < 0-01, n = 38).
The fractionation experiments described in Table III provide direct evidence that in the majority of cases adherent and phagocytic cells are required for optimal in vitro tumour-colony growth in 4 different types of carcinoma. In one case, however, the reverse situation occurred. (Table IV) and measurements of prostaglandin synthetic capacity (Table V) Fig. 1 ). Morphological and functional assessment of the fractions involved in the reconstitution experiments supported the role of the macrophage as the operative cell in this interaction. We cannot exclude the possibility that a subpopulation of lymphoid, granulocytic or tumour cells which also adhere might play an accessory role in this growth-stimulatory process. It is possible that tumour cells produce colony-stimulating activity (CSA) (Okabe et al., 1978) which has been shown to be capable of influencing prostaglandin E production (Kurland et al., 1979) and, furthermore, contaminating polymorphonuclear leucocytes can affect CSA by release of lactoferrin (Broxmeyer et al., 1978) . However, it has previously been reported that phagocytic depletion alone (which would not remove lymphoid cells) markedly reduces tumour-colony growth (Hamburger et al., 1978) reinforcing the central regulatory role of the macrophage. Studies of unfractionated and reconstituted effusion cell populations showed inhibition of tumour-colony growth by addition of indomethacin (Fig. 3) . Further fractionation studies and investigations with synthetic prostaglandins will be required to determine the relationship between inhibition of prostaglandin synthesis and inhibition of tumour-colony formation. Such clonogenicity is undoubtedly based on complex growth requirements and thus we are reluctant to assign a central role of macrophage-derived prostaglandin in this process in lieu of more definite evidence.
The data which we report here indicate that cell cooperation between host and tumour populations has an important role in the determination of in vitro tumour-cell clonogenicity. Responsibility for such stimulatory and inhibitory effects cannot be assigned definitely on the basis of these experiments although the weight of evidence points to the monocyte/macrophage series as being operative. Since the dose response of the interaction shows stimulation at certain concentrations and inhibition at higher levels, it is not surprising that in one patient fractionation increased clonogenicity. It can be suggested that in this patient the status of the cell interaction in the unfractionated effusion was such that clonogenicity was inhibited. Removal of adherent and phagocytic cells released this inhibition. Since no obvious difference could be seen in the morphological differential of this effusion, it must be assumed that the operative stimulating and inhibiting cells in this system are probably a functionally active subpopulation of the morphologically recognizable cell types. Our morphological, phagocytic and prostaglandinsynthetic analyses permit us to identify macrophages clearly as a component of the adherent underlayers. We have not yet assessed the adherent lymphoid cells to determine whether they express markers of B-or T-cell origin.
A number of investigators have recently shown that macrophages can either inhibit or promote growth of tumour cells in vitro (e.g. Norbury, 1977; Mantovani et al., 1979) . Such analyses have been carried out primarily on cell lines or with transplantable animal tumours. Experimental studies demonstrating inhibition of tumour growth have frequently used much larger ratios of macrophages to tumour cells (e.g. 20:1 or 100:1) than we have found in malignant effusions (Table  I) . Stephens et al. (1978) have demonstrated a requirement for tumour cells in the development of macrophage colonies in agar from cells derived from Lewis lung carcinoma, and draw attention to the need to distinguish between CFU-C and tumour colonies in such systems. However, under the conditions of assay employed, and cell types involved in our study, colony formation was restricted to epithelial cells.
The analysis of controlling influences on the primary growth of clonogenic human tumour cells which we report suggest that interactions between host cells and tumour cells occur in human carcinomas, and provide supportive evidence implicating the macrophage as a potential source of stimulation to tumour growth.
